Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name HOXA11-AS
   Synonyms HOXA11-AS, HOXA-AS5, HOXA11-AS1, HOXA11AS, HOXA11S, NCRNA00076
   Region GRCh38_7:27184518-27189293    Sequence
   Ensembl ENSG00000240990
   RefSeq NR_002795
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name breast cancer
   ICD-0-3 C50  
   Methods qPCR etc.
   Sample breast tissues, cell lines (MDA-MB-231, MDA-MB-436, MCF7, T47D)
   Expression Pattern up-regulated
   Function Description

The data revealed that the relative transcript level of HOXA11-AS was upregulated in vivo and in vitro in models of breast cancer. Knockdown of HOXA11-AS in MDA-MB-231 and MDA-MB-436 breast cancer cell lines inhibited the formation of cell colonies and arrested the cell cycle at the G0/G1 phase. Depletion of HOXA11-AS using two specific short interfering (si)RNAs against HOXA11-AS (siHOXA11-AS-1 and siHOXA11-AS-2) additionally suppressed the cell proliferative rate. Furthermore, transwell assays and wound-healing analysis revealed that siRNA transfection inhibited cell migration and invasion by ~50% in the two cell lines. The results of the present study demonstrated the oncogenic role of HOXA11-AS in breast cancer, providing novel clues for the future clinical diagnosis and treatment of early stage breast cancer patients.

   Pubmed ID 28791375
   Year 2017
   Title Long non-coding RNA HOXA11-AS promotes cell proliferation and metastasis in human breast cancer
   External Links
   Links for  HOXA11-AS GenBank       HGNC       lncrnadb       Noncode
   Links for  breast cancer Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.